One analyst called the insurer’s decision a “watershed moment” for liquid biopsy-based cancer screening and for the category ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield™ blood test for colorectal cancer screening (CRC) is now covered for eligible UnitedHealth Group ...

Active-duty service members and eligible family members now have access to blood test for colorectal cancer screening with no copay Shield is the first and only blood test approved by the FDA as a ...

A new blood test for colorectal cancer screening is being implemented in Alabama to improve early detection and reduce deaths from the disease.

Shield Across America mobile screening tour launches during Colorectal Cancer Awareness Month to address nation’s dangerously low screening rates by bringing Shield blood test directly to Americans ...

May 27 (Reuters) - People who skip colorectal cancer screening because colonoscopy or stool testing seems too burdensome now have a blood test option from Guardant Health among recommendations ‌by the ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced that its FDA-approved Shield™ blood test is now included in updated American Cancer Society (ACS) Colorectal Cancer ...

The FDA has approved Guardant Health’s Shield blood test for colon cancer screening. The Shield blood test has been approved as a primary screening method for adults over 45 with an average risk for ...

Commentary: Supporters argue that expanding access to blood-based tests would increase screening rates. Critics counter ...

For the first time, a blood test has been added to the list of the American Cancer Society's recommended screenings for colorectal cancer. It's not meant to replace colonoscopies, aiming instead at ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer screening (CRC) is now covered for active-duty service members and ...